EUVIMEDObjevte EUVIMED
Crossref

Plasma metabolomic profiling for hepatocellular carcinoma diagnosis and microvascular invasion prediction

Fei Huang iD, Huiqin Jiang, Minna Shen, Chunyan Zhang, Yu Chen, Baishen Pan, Beili Wang, Wei Guo, Wenjing Yang

International Journal of Cancer · 2025-11-15 · 157 (10) · 2187-2196

DOI: 10.1002/ijc.70055 ↗

At a glance

Journal article in International Journal of Cancer, published online on 2025-07-22. Written by Fei Huang and 8 co-authors. Institution: Department of Laboratory Medicine, Zhongshan Hospital, Fudan University, Shanghai, China. Major MEDLINE topics: Carcinoma, Hepatocellular, Liver Neoplasms, Metabolomics, Biomarkers, Tumor. Cited 4 times so far (Crossref); 36 references. Funded by: National Natural Science Foundation of China, Shanghai Baoshan Medical Key Specialty, Shanghai Key Clinical Specialty Construction Project.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Altered metabolites are pivotal in hepatocellular carcinoma (HCC) development. This study employed untargeted metabolomic analysis to identify novel biomarkers for early HCC detection and explore their functions. Plasma samples were collected from 138 HCC patients, 69 patients with benign hepatic lesions, and 35 healthy donors. These samples were divided into a discovery set of 171 and a validation set of 71, and analyzed using ultra high performance liquid chromatography mass spectrometry. Through paired t ‐tests and orthogonal partial least‐squares discriminant analysis, nine metabolites with significant predictive value were selected out and incorporated into a model for HCC diagnosis. Area under curves for the discovery set, the validation set, and all samples were 0.97, 0.95, and 0.96, respectively. The satisfactory diagnostic performance was maintained regardless of the China liver cancer (CNLC) staging. Additionally, this model demonstrated better diagnostic performance than alpha‐fetoprotein (AFP) when comparing HCC to controls in different CNLC stages. The metabolite pathway enrichment analysis showed that alterations in plasma bile acids were associated with cirrhosis. Univariate and multivariate analyses indicated that the ratio of L‐Serine and Sarcosine was an independent predictor for microvascular invasion (MVI). An integrated analysis of metabolomic data with transcriptomic data from the Cancer Genome Atlas revealed that the low expression of alanine glyoxylate aminotransferase (AGXT) and glycine amidinotransferase (GATM) was more likely related to MVI. To sum up, our research findings may offer valuable insights into HCC metabolic alterations and contribute to a better characterization of HCC.

Subjects

MeSH terms (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsMetabolomicsBiomarkers, TumorHumansMaleFemaleMiddle AgedAdultNeoplasm InvasivenessAgedCase-Control StudiesMetabolomeMicrovesselsalpha-Fetoproteins

Author keywords

cirrhosishepatocellular carcinomamicrovascular invasionuntargeted metabolomic profiling

Substances

Biomarkers, Tumoralpha-Fetoproteins

Authors and institutions

  • Department of Laboratory Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Department of Laboratory Diagnostics, KingMed Center for Clinical Laboratory, Shanghai, China.
  • Department of Laboratory Medicine, Shanghai Geriatric Medical Centre, Shanghai, China.
  • Department of Laboratory Medicine, Xiamen Branch, Zhongshan Hospital, Fudan University, Xiamen, China.
  • Department of Laboratory Medicine, Wusong Branch, Zhongshan Hospital, Fudan University, Shanghai, China.

ORCID profiles: Fei Huang

Funding

  • National Natural Science Foundation of China
  • Shanghai Baoshan Medical Key Specialty
  • Shanghai Key Clinical Specialty Construction Project

Cite

APA

Huang, F., Jiang, H., Shen, M., Zhang, C., Chen, Y., Pan, B., Wang, B., Guo, W., & Yang, W. (2025). Plasma metabolomic profiling for hepatocellular carcinoma diagnosis and microvascular invasion prediction. International Journal of Cancer, 157(10), 2187-2196. https://doi.org/10.1002/ijc.70055

Vancouver

Huang F, Jiang H, Shen M, Zhang C, Chen Y, Pan B, et al. Plasma metabolomic profiling for hepatocellular carcinoma diagnosis and microvascular invasion prediction. International Journal of Cancer. 2025;157(10):2187-2196. doi:10.1002/ijc.70055

BibTeX
@article{Huang2025,
  author = {Huang, Fei and Jiang, Huiqin and Shen, Minna and Zhang, Chunyan and Chen, Yu and Pan, Baishen and Wang, Beili and Guo, Wei and Yang, Wenjing},
  title = {Plasma metabolomic profiling for hepatocellular carcinoma diagnosis and microvascular invasion prediction},
  journal = {International Journal of Cancer},
  year = {2025},
  volume = {157},
  number = {10},
  pages = {2187--2196},
  doi = {10.1002/ijc.70055}
}
Start for free →